The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa)

被引:0
|
作者
Parth Patel
Shu Wang
Mohummad Minhaj Siddiqui
机构
[1] University of Maryland Medical Center,Division of Urology, Department of Surgery
来源
Current Urology Reports | 2019年 / 20卷
关键词
Prostate cancer; mpMRI; Fusion biopsy; Targeted biopsy; Pre-biopsy MRI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa)
    Patel, Parth
    Wang, Shu
    Siddiqui, Mohummad Minhaj
    [J]. CURRENT UROLOGY REPORTS, 2019, 20 (10)
  • [2] Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer
    Ingole, Sarang M.
    Mehta, Rajeev U.
    Kazi, Zubair N.
    Bhuyar, Rutuja, V
    [J]. INDIAN JOURNAL OF RADIOLOGY AND IMAGING, 2021, 31 (01): : 65 - 77
  • [3] Precision of multiparametric Prostate Magnetic Resonance Imaging for the Detection of clinically significant Prostate Cancer
    Krafft, U.
    Borkowetz, A.
    [J]. UROLOGE, 2020, 59 (01): : 72 - 77
  • [4] UTILITY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) IN THE EVALUATION OF MEN FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER
    Salami, Simpa
    Sonstegard, Anna Marie
    Yaskiv, Oksana
    Turkbey, Baris
    Villani, Robert
    Ben-Levi, Eran
    Rastinehad, Ardeshir
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E122 - E123
  • [5] Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer
    O’Connor, Luke
    Wang, Alex
    Walker, Stephanie M.
    Yerram, Nitin
    Pinto, Peter A.
    Turkbey, Baris
    [J]. Expert Review of Medical Devices, 2020, 17 (05): : 435 - 442
  • [6] Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer
    O'Connor, Luke
    Wang, Alex
    Walker, Stephanie M.
    Yerram, Nitin
    Pinto, Peter A.
    Turkbey, Baris
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (05) : 435 - 442
  • [7] PSA DENSITY (PSAD) ALONE OR WITH MULTIPARAMETRIC MRI (MPMRI) IS ROBUST AT PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA)
    Pandya, Shashank S.
    Andreas, Darian
    Nethala, Daniel
    Lee, Jeffrey
    Hall, Simon J.
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E506 - E506
  • [8] Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging
    Chaloupka, M.
    Bischoff, R.
    Pfitzinger, P.
    Lellig, E.
    Ledderose, S.
    Buchner, A.
    Schlenker, B.
    Stief, C.
    Clevert, D-A
    Apfelbeck, M.
    [J]. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2019, 73 (01) : 105 - 111
  • [9] Multiparametric magnetic resonance imaging-targeted biopsies in the detection of clinically significant prostate cancer
    Charalampos, Fragkoulis
    [J]. INDIAN JOURNAL OF UROLOGY, 2020, 36 (03) : 229 - 230
  • [10] The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging
    Quarta, L.
    Scuderi, S.
    Gandaglia, G.
    Stabile, A.
    Marzorati, C.
    Russo, T.
    Brembilla, G.
    Camisassa, E.
    Leni, R.
    Cucchiara, V.
    Bianchi, M.
    Cannoletta, D.
    Zaurito, P.
    Barletta, F.
    Cosenza, M.
    Robesti, D.
    Mazzone, E.
    De Cobelli, F.
    Montorsi, F.
    Briganti, A.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S61 - S61